DOCSLIB.ORG

Keeping His Heart in the Game Surgery with Minimal Cuts Offers Quick Recovery, P

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Keeping His Heart in the Game Surgery with Minimal Cuts Offers Quick Recovery, P NEWS OF THE TEXAS MEDICAL CENTER — VOL. 5 / NO. 9 — OCTOBER 2018 NEWS OFOF THETHE TEXASTEXAS MEDICALMEDICAL CENTER CENTER — — VOL. VOL. 5 5/ NO./ NO. 8 9— —SEPTEMBER OCTOBER 20182018 Keeping His Heart in the Game Surgery with minimal cuts offers quick recovery, p. 20 STDs HIT A TOOLKIT FOR BREAST RECORD HIGH, NEWBORNS RECONSTRUCTION p. 12 IN NEED, REVOLUTION, p. 14 p. 29 CENTERED LIVING LUXURY APARTMENT HOMES In The Houston Medical Center MICRO UNITS TO PENTHOUSES 10 Weeks Free Rent* Book Your Tour Today 713-527-1000 EQUAL HOUSING OPPORTUNITY *Restrictions May Apply. Ask for Details. LatitudeMedCenter.com *Restrictions May Apply. Ask for Details. President’s Perspective TMC | PULSE Vol. 5 No. 9 October 2018 President and Chief Executive Officer William F. McKeon Communications Director Ryan Holeywell Pulse Editor Maggie Galehouse [email protected] Assistant Editor Cindy George [email protected] Staff Writers Alexandra Becker Mark Mulligan/© Houston Chronicle. Used with permission. with Used Chronicle. Houston Mark Mulligan/© Christine Hall WILLIAM F. McKEON Britni R. McAshan President and Chief Executive Officer Shanley Pierce Texas Medical Center Photojournalist Cody Duty recently traveled to London and, together with of Leeds, with the leadership of the Texas Medical United Kingdom government and research leader- Center. Researchers from both countries will collab- Contributing Photographer I ship, announced a BioBridge partnership between orate on a range of projects, including the devel- Scott Dalton the Texas Medical Center and the UK. This unique opment and advancement of genomics and cancer NEWSROOM collaboration is a testament to the Texas Medical treatments. For example, researchers are developing 713-791-8812 Center (TMC) and the UK’s commitment to fostering ways to use artificial intelligence to target treatments [email protected] the cross-pollination of ideas and innovation in the based on an individual’s distinctive genomic profile. life sciences to accelerate discovery. It was exciting to see the genuine support and ADVERTISING What, exactly, does this part- enthusiasm from UK partners, Felicia Zbranek-Zeitman nership mean? First, it solves a including Baroness Rona Fairhead, 713-791-8829 key challenge facing early stage UK Minister of State for the [email protected] companies. Those startups require Department of International Trade; DISTRIBUTION a great deal of nurturing and and Sir Mark Walport, chief exec- Daniel Martinez support, and that’s especially true utive of UK Research Innovation, 713-791-6136 when they expand beyond their a government funding agency; [email protected] home country into new markets. along with leaders of some of the READ US ONLINE most prestigious universities in The BioBridge aligns the life sci- tmc.edu/news ence startup communities across the United Kingdom and the Texas the UK with the TMC Innovation McKeon, Fairhead and Walport Medical Center. FOLLOW US Institute. UK-based companies are Importantly, we don’t see @TXMedCenter now able to house themselves at the TMC and tap this as a one-time partnership. We’ve established a @texasmedcenter @thetexasmedicalcenter into our network of investors and experts. And the BioBridge with Australia, as well, and we expect to reverse is true, too: startups housed here at the develop more of these types of relationships as we TMC Pulse is an award-winning continue to advance the Texas Medical Center’s role TMC now will have an access point into the UK. monthly publication of the Texas The BioBridge serves as a mutual port of entry, as an international leader—and partner—in the Medical Center in Houston, Texas. where startups can establish a base and learn the life sciences. Permission from the editor is regulatory nuances of a new market while building Our BioBridge partnership is designed to share required to reprint any material. key relationships. knowledge, technologies and insights to leverage our Second, the BioBridge aligns leading UK insti- collective capabilities to develop treatments faster. tutions, including Cambridge University, Oxford We are united in our passion and dedication for University, Manchester University and the University improving the health of humanity. 2 t m c » p u l s e | o c to b e r 2018 Table of Contents OCTOBER 2018 6 On the Side: Christina Wells 8 Spotlight: William Zoghbi, M.D. 33 Curated: Smiles are Contagious 38 Field Notes 40 Calendar on this page: Rebecca Richards-Kortum, Ph.D., professor of bioengineering and director of the Rice 360° Institute for Global Health at Rice University, in her lab at the BioScience Research Collaborative. on the cover: Ethan Page performs a drill during baseball practice. 4 26 34 36 Analysis: Health Care Vampire Facial: Solutions: Connecting the Digital Pathology Shouldn’t Cause Not that Bloody Warburg Pathway to Improving Diagnoses Financial Pain Cancer Growth Analysis: Health Care Shouldn’t Cause Financial Pain Studies show Americans are feeling the squeeze By Ryan Holeywell gruesome scene played out earlier this year For many, the status quo means that a growing Ain Boston that illustrates the state of health WHAT HAPPENS percentage of family income will continue to go care for many of today’s consumers. As a pas- WHEN YOU RECEIVE A toward health care costs at the expense of saving senger exited a rush-hour transit train, her foot COSTLY MEDICAL BILL? for retirement, college or starting a business. got caught in the gap between the train and the National Results The realities of managing medical bills can have platform. Bloodied, with a laceration deep enough a major, disruptive effect on Americans’ lives. to reveal bone, she begged nearby commuters About 60 percent of people who say they struggle n Pay in full not to call an ambulance. “It’s $3,000,” she said, with medical bills exhaust most or all of their right away according to a Boston Globe reporter on the scene. savings to pay them. The same proportion take 37.5% “I can’t afford that.” n Pay what I can, on second jobs or work more hours to pay The story went viral, garnering national when I can medical bills. attention for how perfectly it captured the terrible For American families, the prospect of losing n dilemma many Americans face when they interact Pay in agreed everything due to an unfortunate combination of upon installments 23.8% with the United States health care system. The injury and inadequate insurance is an ever- system can ease patients’ physical pain, but, in n Don’t pay until present threat. One recent study found that med- exchange, it often demands that they endure collection agency ical bills are the single largest cause of consumer extreme financial pain. 29.2% bankruptcy, responsible for between 18 and 25 New survey data from the Texas Medical n Don’t pay percent of cases. Two-thirds of Americans who 2.5% Center Health Policy Institute sheds light on how struggle with their medical bills say they’re the 6.9% that predicament affects families across the coun- result of a one-time, short-term expense, such as a try. For example, the survey shows that nearly single hospital stay or treatment for an accident, Due to rounding, total does not add up to 100%. two-thirds of Americans can’t pay the bill in full according to a Kaiser Family Foundation survey. when they receive a costly invoice for medical In other words, even if you think you’re healthy, care. Half of Americans say they must cut back I HAVE TO CUT DOWN you could be at risk. on other household expenses to pay for their The U.S. has been a center of medical inno- health care. ON OTHER EXPENSES vation, developing cutting edge drugs, proce- These were problems that should have been TO PAY FOR HEALTH CARE dures and tests to identify and fight disease. But eased by now. More than eight years after the National Results the country has failed to innovate in an equally Affordable Care Act became law, health care costs important area: developing policies to ensure that continue to challenge families. Americans of n Strongly all patients can utilize those advancements. It all types are feeling the squeeze. For those with agree should come as no surprise that most Americans 18% Marketplace (Obamacare) plans, premiums have 27% say they delay necessary medical care due to cost. doubled in just five years, and family deductibles n Somewhat Do we want our friends to take on second jobs agree average a staggering $11,500. Those who get 31% if they are unlucky enough to get sick? Do we 24% insurance through their employers face their own n Somewhat want our family members to lose their retirement challenges. Premiums are increasing faster than disagree savings if they have the bad fortune to suffer an wages and a growing number of businesses are accident? Citizens of most other Western coun- steering their employees toward high-deductible n Strongly tries have answered “of course not.” In the U.S., disagree health plans that force workers to bear a growing many observers have been asking whether rising share of health care costs. And, of course, the health care costs are sustainable. The truth is, they 10 percent of non-elderly adults without any Source: “The Nation’s Pulse: The Texas Medical Center’s Consumer Survey,” probably are—the trend has continued unabated health insurance are in the most precarious which pulled data from more than 5,000 participants nationwide for years. The real question is whether we will position of all. continue to accept them. Ryan Holeywell leads communications for the Texas Medical Center Health Policy Institute. 4 t m c » p u l s e | o c to b e r 2018 t m c » p u l s e | o c to b e r 2018 Please don’t say, I wish I’d done “something sooner.
Load more

Recommended publications
  • Huda Zoghbi: Taking Genetic Inquiry to the Next Level
    Spectrum | Autism Research News https://www.spectrumnews.org NEWS, PROFILES Huda Zoghbi: Taking genetic inquiry to the next level BY RACHEL ZAMZOW 25 JUNE 2021 Listen to this story: Most mornings, Huda Zoghbi, 67, climbs a glass-encased, curling staircase to reach her lab on the top and 13th floor of the Jan and Dan Duncan Neurological Research Institute in Houston, Texas. The twisting glass tower, which she designed with a team of architects, echoes the double helix of DNA — a structure that has been central to her career-long quest to uncover genes underlying neurological conditions. As the institute’s director — and as a scientist— she is known for going beyond the standard job description. Genetics researchers often cast a wide net and sequence thousands of genes at a time. But in her prolific career, Zoghbi has focused on a handful of genes, methodically building up an understanding of their function one careful step at a time. Thanks to that approach, Zoghbi has made a number of landmark discoveries, including identifying the genetic roots of Rett syndrome, an autism-related condition that primarily affects girls, as well as the genetic mutations that spur spinocerebellar ataxia, a degenerative motor condition. She has authored more than 350 journal articles. Her accomplishments have earned her almost every major biology and neuroscience research award, including the prestigious Breakthrough Prize in 2017 and the Brain Prize in 2020. “She’s clearly the international leader in the field,” said the late Stephen Warren, professor of human genetics at Emory University in Atlanta, Georgia. Zoghbi never set out to lead a large research center, she says — her heart is in the lab.
    [Show full text]
  • Oncorequisite Role of an Aldehyde Dehydrogenase in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia
    Acute Lymphoblastic Leukemia SUPPLEMENTARY APPENDIX Oncorequisite role of an aldehyde dehydrogenase in the pathogenesis of T-cell acute lymphoblastic leukemia Chujing Zhang, 1 Stella Amanda, 1 Cheng Wang, 2 Tze King Tan, 1 Muhammad Zulfaqar Ali, 1 Wei Zhong Leong, 1 Ley Moy Ng, 1 Shojiro Kitajima, 3 Zhenhua Li, 4 Allen Eng Juh Yeoh, 1,4 Shi Hao Tan 1 and Takaomi Sanda 1,5 1Cancer Science Institute of Singapore, National University of Singapore, Singapore; 2Department of Anatomy, National University of Singapore, Singapore; 3Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan; 4VIVA-NUS CenTRAL, Department of Pedi - atrics, National University of Singapore, Singapore and 5Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. ©2021 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2019.245639 Received: December 18, 2019. Accepted: May 14, 2020. Pre-published: May 15, 2020. Correspondence: TAKAOMI SANDA - [email protected] Zhang et al Roles of ALDH in T-ALL Supplementary Information Supplementary Materials and Methods Cell culture and reagents All human leukemia cell lines were cultured in RPMI-1640 medium (BioWest) supplemented with 10% FBS (BioWest). 293T cells were maintained in DMEM medium (BioWest) supplemented with 10% FBS and penicillin/streptomycin (Life Technologies). All-trans retinaldehyde was purchased from Sigma-Aldrich. Glucose free and Glutamine free RPMI- 1640 media were purchased from ThermoFisher. Patient derived xenograft (PDX) sample T-ALL patient-derived PDX sample (DFCI15) was kindly provided by Alejandro Gutierrez (Boston Children’s Hospital, Boston). Mouse studies were conducted according to the recommendations from the Institutional Animal Care and Use Committee (IACUC) and all protocols were approved by the Committee at the National University of Singapore (NUS).
    [Show full text]
  • Emerging Roles of P53 Family Members in Glucose Metabolism
    International Journal of Molecular Sciences Review Emerging Roles of p53 Family Members in Glucose Metabolism Yoko Itahana and Koji Itahana * Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore; [email protected] * Correspondence: [email protected]; Tel.: +65-6516-2554; Fax: +65-6221-2402 Received: 19 January 2018; Accepted: 22 February 2018; Published: 8 March 2018 Abstract: Glucose is the key source for most organisms to provide energy, as well as the key source for metabolites to generate building blocks in cells. The deregulation of glucose homeostasis occurs in various diseases, including the enhanced aerobic glycolysis that is observed in cancers, and insulin resistance in diabetes. Although p53 is thought to suppress tumorigenesis primarily by inducing cell cycle arrest, apoptosis, and senescence in response to stress, the non-canonical functions of p53 in cellular energy homeostasis and metabolism are also emerging as critical factors for tumor suppression. Increasing evidence suggests that p53 plays a significant role in regulating glucose homeostasis. Furthermore, the p53 family members p63 and p73, as well as gain-of-function p53 mutants, are also involved in glucose metabolism. Indeed, how this protein family regulates cellular energy levels is complicated and difficult to disentangle. This review discusses the roles of the p53 family in multiple metabolic processes, such as glycolysis, gluconeogenesis, aerobic respiration, and autophagy. We also discuss how the dysregulation of the p53 family in these processes leads to diseases such as cancer and diabetes. Elucidating the complexities of the p53 family members in glucose homeostasis will improve our understanding of these diseases.
    [Show full text]
  • Summer 2018 Meet the Committee
    SUMMER NEWSLETTER 2018 IN THIS ISSUE: Letter from the Chair 2 Meet the Committee 3 2018 Annual Appeal Update 4 News & Events 5 Biggest Hearts 6 Cardiovascular Challenge 7 Chain Reaction Donation Challenge 8 Images from the Heart Photo Exhibit 9 9th Annual Research Awards Gala 10 Your Donations In Action: 2018 Scholarship & Grant Recipients 12 Recipient Testimonials: Your Donations Support the Progress and Future of Echocardiography 16 Thank you to our 2018 Annual Appeal Investors 17 ASE FOUNDATION • 2530 Meridian Parkway, Suite 450 • Durham, NC 27713 [email protected] • ASEFoundation.org A Time for Reflection and a Look Ahead Jose Banchs, MD, FASE, 2018-2019 ASE Foundation Annual Appeal Committee Chairman n my first chairman’s letter, Summer of 2016, I shared my A total of 14 photos were on display for this year’s exhibit, reason for becoming involved in the ASEF committee: I and they garnered much attention. The images, including I wanted to pay forward all the benefits I have received some from past years’ exhibits, were available to take home from this Society. These benefits, including educational in exchange for a donation in the photographer’s name. A and professional rewards, would not be possible without few were so popular that we contacted the photographers the support of the ASE Foundation donors. Coming on the and arranged for more copies to be made available. By the heels of the annual Scientific Sessions, I think it’s fitting to end of the meeting, the exhibit resulted in more than $1,450 highlight the numerous ways the ASE Foundation uses the in donations! money it raises.
    [Show full text]
  • 6-Phosphofructo-2-Kinase/Fructose-2
    Published OnlineFirst August 7, 2019; DOI: 10.1158/1078-0432.CCR-18-3448 Translational Cancer Mechanisms and Therapy Clinical Cancer Research 6-Phosphofructo-2-Kinase/Fructose-2,6- Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers Hailing Yang1, Zhang Shu1,2,Yongying Jiang3, Weiqun Mao1, Lan Pang1, Abena Redwood4, Sabrina L. Jeter-Jones4, Nicholas B. Jennings5, Argentina Ornelas6, Jinhua Zhou1, Cristian Rodriguez-Aguayo1,7, Geoffrey Bartholomeusz1, LaKesla R. Iles1, Niki M. Zacharias8, Steven W. Millward6, Gabriel Lopez-Berestein1,7, Xiao-Feng Le1, Ahmed A. Ahmed9,10, Helen Piwnica-Worms4, Anil K. Sood5,7, Robert C. Bast1, and Zhen Lu1 Abstract Purpose: Paclitaxel is an integral component of primary Results: Knockdown of PFKFB2 inhibited clonogenic therapy for breast and epithelial ovarian cancers, but less than growth and enhanced paclitaxel sensitivity in ovarian and half of these cancers respond to the drug. Enhancing the breast cancer cell lines with wild-type TP53 (wtTP53). response to primary therapy with paclitaxel could improve Silencing PFKFB2 significantly inhibited tumor growth and outcomes for women with both diseases. enhanced paclitaxel sensitivity in four xenografts derived Experimental Design: Twelve kinases that regulate from two ovarian and two breast cancer cell lines, and metabolism were depleted in multiple ovarian and breast prolonged survival in a triple-negative breast cancer PDX. cancer cell lines to determine whether they regulate sensi- Transfection of siPFKFB2 increased the glycolysis rate, but tivity to paclitaxel in Sulforhodamine B assays. The effects decreased the flow of intermediates through the pentose– of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase phosphate pathway in cancer cells with wtTP53,decreasing 2(PFKFB2) depletion on cell metabolomics, extracellular NADPH.
    [Show full text]
  • Identification and Validation of a Six-Gene Signature Associated With
    Cai et al. BMC Cancer (2020) 20:1133 https://doi.org/10.1186/s12885-020-07598-3 RESEARCH ARTICLE Open Access Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer Luya Cai1†, Chuan Hu2†, Shanshan Yu3, Lixiao Liu1, Xiaobo Yu1, Jiahua Chen1, Xuan Liu1, Fan Lin4, Cheng Zhang4, Wenfeng Li3 and Xiaojian Yan1* Abstract Background: Cervical cancer (CC) is one of the most common gynaecological cancers. The gene signature is believed to be reliable for predicting cancer patient survival. However, there is no relevant study on the relationship between the glycolysis-related gene (GRG) signature and overall survival (OS) of patients with CC. Methods: We extracted the mRNA expression profiles of 306 tumour and 13 normal tissues from the University of California Santa Cruz (UCSC) Database. Then, we screened out differentially expressed glycolysis-related genes (DEGRGs) among these mRNAs. All patients were randomly divided into training cohort and validation cohort according to the ratio of 7: 3. Next, univariate and multivariate Cox regression analyses were carried out to select the GRG with predictive ability for the prognosis of the training cohort. Additionally, risk score model was constructed and validated it in the validation cohort. Results: Six mRNAs were obtained that were associated with patient survival. The filtered mRNAs were classified into the protective type (GOT1) and the risk type (HSPA5, ANGPTL4, PFKM, IER3 and PFKFB4). Additionally, by constructing the prognostic risk score model, we found that the OS of the high-risk group was notably poorer, which showed good predictive ability both in training cohort and validation cohort.
    [Show full text]
  • Glycolytic Reliance Promotes Anabolism in Photoreceptors
    bioRxiv preprint doi: https://doi.org/10.1101/101964; this version posted January 21, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Glycolytic reliance promotes anabolism in photoreceptors Yashodhan Chinchore, Tedi Begaj, David Wu, Eugene Drokhlyansky, Constance L. Cepko* *Departments of Genetics and Ophthalmology, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115, USA [email protected] bioRxiv preprint doi: https://doi.org/10.1101/101964; this version posted January 21, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Sensory neurons capture information from the environment and convert it 2 into signals that can greatly impact the survival of an organism. These systems 3 are thus under heavy selective pressure, including for the most efficient use of 4 energy to support their sensitivity and efficiency1. In this regard, the 5 vertebrate photoreceptor cells face a dual challenge. They not only need to 6 preserve their membrane excitability via ion pumps by ATP hydrolysis2 but 7 also maintain a highly membrane rich organelle, the outer segment, which is 8 the primary site of phototransduction, creating a considerable biosynthetic 9 demand. How photoreceptors manage carbon allocation to balance their 10 catabolic and anabolic demands is poorly understood. One metabolic feature 11 of the retina is its ability to convert the majority of its glucose into lactate3,4 12 even in the presence of oxygen.
    [Show full text]
  • High Expression of Metabolic Enzyme PFKFB4 Is Associated with Poor
    Yao et al. Cancer Cell Int (2019) 19:165 https://doi.org/10.1186/s12935-019-0882-2 Cancer Cell International PRIMARY RESEARCH Open Access High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer Ling Yao1,2,3†, Lei Wang1,2,3†, Zhi‑Gang Cao1,2,3, Xin Hu1,2,3* and Zhi‑Ming Shao1,2,3,4* Abstract Background: Enhanced glycolysis in tumors, known as the Warburg efect, provides the metabolic basis of enhanced cancer cell proliferation and metastasis. The Warburg pathway enzyme 6‑phosphofructo‑2‑kinase/fructose‑ 2,6‑bisphosphatase 4 (PFKFB4) is a newly identifed key kinase that regulates transcriptional reprogramming and cell proliferation. Here we show the prognostic value of PFKFB4 expression in patients with operable breast cancer. Methods: PFKFB4 expression was evaluated by immunohistochemistry in surgical specimens retrospectively col‑ lected from 200 patients with histologically proven invasive ductal breast cancer. Kaplan–Meier survival analysis and Cox regression analysis were performed to assess the prognostic signifcance of PFKFB4 expression. Results: Kaplan–Meier survival analysis revealed that breast cancer patients with high PFKFB4 expression demon‑ strated unfavorable disease‑free survival (p 0.008) and overall survival (p 0.002). PFKFB4 had an hazard ratio (HR) of 7.38 (95% CI 1.69–32.3; p 0.008) in univariate= Cox analysis and retained prognostic= power (HR 7.44, 95% CI 1.67–33.2; p 0.009) when adjusted= by tumor size, lymph node status, grade, estrogen receptor status, human epidermal growth= factor receptor 2 status and subtype, which indicated PFKFB4 was an independent prognostic factor in breast cancer.
    [Show full text]
  • Altered Gene Expression Along the Glycolysis– Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer Joanna M
    Published OnlineFirst September 3, 2019; DOI: 10.1158/1078-0432.CCR-19-1543 Precision Medicine and Imaging Clinical Cancer Research Altered Gene Expression along the Glycolysis– Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer Joanna M. Karasinska1, James T. Topham1, Steve E. Kalloger1,2, Gun Ho Jang3, Robert E. Denroche3, Luka Culibrk4, Laura M.Williamson4, Hui-Li Wong5, Michael K.C. Lee5, Grainne M. O'Kane6, Richard A. Moore4, Andrew J. Mungall4, Malcolm J. Moore5, Cassia Warren1, Andrew Metcalfe1, Faiyaz Notta3, Jennifer J. Knox6, Steven Gallinger3,6, Janessa Laskin4,5, Marco A. Marra4,7, Steven J.M. Jones4,7, Daniel J. Renouf1,5,8, and David F. Schaeffer1,2,9 Abstract Purpose: Identification of clinically actionable molecular groups were identified: quiescent, glycolytic, cholestero- subtypes of pancreatic ductal adenocarcinoma (PDAC) is key genic, and mixed. Glycolytic tumors were associated with to improving patient outcome. Intertumoral metabolic hetero- the shortest median survival in resectable (log-rank test geneity contributes to cancer survival and the balance between P ¼ 0.018) and metastatic settings (log-rank test P ¼ distinct metabolic pathways may influence PDAC outcome. We 0.027). Patients with cholesterogenic tumors had the lon- hypothesized that PDAC can be stratified into prognostic gest median survival. KRAS and MYC-amplified tumors metabolic subgroups based on alterations in the expression of had higher expression of glycolytic genes than tumors with genes involved in glycolysis and cholesterol synthesis. normal or lost copies of the oncogenes (Wilcoxon rank Experimental Design: We performed bioinformatics analy- sum test P ¼ 0.015). Glycolytic tumors had the lowest sis of genomic, transcriptomic, and clinical data in an integrated expression of mitochondrial pyruvate carriers MPC1 and cohort of 325 resectable and nonresectable PDAC.
    [Show full text]
  • Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic
    nutrients Article Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines Malgorzata Tyszka-Czochara 1,* ID , Karolina Bukowska-Strakova 2, Kinga A. Kocemba-Pilarczyk 3 and Marcin Majka 4,* ID 1 Department of Food Chemistry and Nutrition, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland 2 Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Wielicka 265, 30-663 Krakow, Poland; [email protected] 3 Faculty of Medicine, Jagiellonian University-Medical College, Kopernika 7, 31-034 Krakow, Poland; [email protected] 4 Department of Department of Transplantation, Faculty of Medicine, Jagiellonian University Medical College, Wielicka 258, 30-688 Krakow, Poland * Correspondence: [email protected] (M.T.-C.); [email protected] (M.M.); Tel.: +48-(12)6205670 (M.T.-C.); +48-(12)6591593 (M.M.) Received: 22 May 2018; Accepted: 25 June 2018; Published: 28 June 2018 Abstract: The small molecules, natural antioxidant Caffeic Acid (trans-3,4-Dihydroxycinnamic acid CA) and anti-diabetic drug Metformin (Met), activate 50-adenosine monophosphate-activated protein kinase (AMPK) and interfere with metabolic reprogramming in human cervical squamous carcinoma cells. Here, to gain more insight into the ability of CA, Met and the combination of both compounds to impair aerobic glycolysis (the “Warburg effect”) and disrupt bioenergetics of cancer cells, we employed the cervical tumor cell lines C-4I and HTB-35/SiHa. In epithelial C-4I cells derived from solid tumors, CA alleviated glutamine anaplerosis by downregulation of Glutaminase (GLS) and Malic Enzyme 1 (ME1), which resulted in the reduction of NADPH levels.
    [Show full text]
  • The Metabolic Role of PFKFB4 in Androgen-Independent Growth In
    Li et al. BMC Urology (2020) 20:61 https://doi.org/10.1186/s12894-020-00635-0 RESEARCH ARTICLE Open Access The metabolic role of PFKFB4 in androgen- independent growth in vitro and PFKFB4 expression in human prostate cancer tissue Ximing Li1,2, Zhi Chen1, Zuan Li1, Guihai Huang1, Junhao Lin1, Qiang Wei3, Jianbo Liang1 and Wei Li1* Abstract Background: It is well known that androgen-deprivation therapy (ADT) can inevitably drive prostate cancer (PCa) cells into a castration-resistant state. According to the “Warburg effect”, the metabolism of aggressive tumor cells increases significantly. The growth of cancer cells depends on glycolysis, which may be a potential target for cancer control. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) plays key roles in the proliferation and metastasis of PCa cells. However, there is very limited knowledge on the role of PFKFB4 in the conversion to castration resistance. The present study aimed to determine the changes in glucose consumption and PFKFB4 expression in LNCaP cells and androgen-independent LNCaP (LNCaP-AI) cells during the whole process of androgen-independent growth. Additionally, PFKFB4 expression in human PCa tissues was evaluated. Methods: We established an androgen-independent LNCaP-AI cell line derived from LNCaP cells to mimic the traits of castration resistance in vitro. LNCaP-AI and LNCaP cells were cultured in the corresponding medium containing the same amount of glucose. At the end of experiments, the medium supernatant and blank medium were collected, and absorbance was measured. LNCaP-AI and LNCaP cells were harvested to detect PFKFB4 expression by Western blotting.
    [Show full text]
  • Analysis of Malignant Melanoma Cell Lines Exposed to Hypoxia Reveals the Importance of PFKFB4 Overexpression for Disease Progression SONIA E
    ANTICANCER RESEARCH 38 : 6745-6752 (2018) doi:10.21873/anticanres.13044 Analysis of Malignant Melanoma Cell Lines Exposed to Hypoxia Reveals the Importance of PFKFB4 Overexpression for Disease Progression SONIA E. TROJAN 1, MONIKA PIWOWAR 2, BARBARA OSTROWSKA 1, PIOTR LAIDLER 1* and KINGA A. KOCEMBA-PILARCZYK 1* 1Chair of Medical Biochemistry, 2Department of Bioinformatics and Telemedicine, Faculty of Medicine, Jagiellonian University – Medical College, Cracow, Poland Abstract. Background/Aim: Most melanomas develop in for melanin production. One of the major risk factors for hypoxic conditions. Since hypoxia via HIF-1 induces glycolysis, melanoma is chronic sun exposure of the skin, leading to a process essential for malignant melanoma growth/survival, UV- induced melanocyte mutations, especially within NRAS, the goal of this study was to analyze the influence of hypoxia BRAF and cKIT protooncogenes (5). On the other hand, a on the expression of HIF-1 target genes involved in glucose considerable group of melanoma patients reports a family metabolism. Materials and Methods: The response of melanoma history of disease, pointing out the hereditary background of cell lines to hypoxic conditions was analyzed by RT-PCR and this highly lethal cancer, characterized predominantly by western blotting. A Kaplan–Meier survival analysis for patients BRAF mutations (5, 6). In general, mutations in the genes with high and low expression level of PFKFB4 was performed. involved in proliferation, apoptosis, metabolism and cell Further analysis of patients’ data was performed using the cycle constitute the main cause of malignant melanoma R/Bioconductor environment. Results: Induction of PFKFB4 transformations (5). gene expression can be considered a crucial mechanism behind Although the genetic alterations in melanocytic DNA are glycolysis enhancement in hypoxic melanoma cells.
    [Show full text]